Peter Attia· MD
so you're saying that maybe $50,000 or oh it might be that much more okay again still relatively inexpensive compared to to to the whole thing to a lifetime of therapy
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so you're saying that maybe $50,000 or oh it might be that much more okay again still relatively inexpensive compared to to to the whole thing to a lifetime of therapy
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the drug that inhibits pcsk9 inhibitor and there are three of them out there right you know these are when they came out they were $155,000 a year drugs now they're $6,000 a year drugs